Abstract:Cancer is the world's leading cause of death impacting millions of lives globally. The increasing research over the past several decades has focused on the development of new anticancer drugs, but still cancer continues to be a global health challenge. Thus, several new alternative therapeutic strategies have been tried for the drug design and discovery. Purine and pyrimidine heterocyclic compounds have received attention recently due to their potential in targeting various cancers. It is evident from the recently published data over the last decade that incorporation of the purine and pyrimidine rings in the synthesized derivatives resulted in the development of potent anticancer molecules. This review presents synthetic strategies encompassing several examples of recently developed purine and pyrimidine-containing compounds as anticancer agents. In addition, their structure–activity relationships are represented in the schemes indicating the fragment or groups that are essential for the enhanced anticancer activities. Purine and pyrimidines combined with other heterocyclic compounds have resulted in many novel anticancer molecules that address the challenges of drug resistance. The purine and pyrimidine derivatives showed significantly enhanced anticancer activities against targeted receptor proteins with numerous compounds with an IC 50 value in the nanomolar range. The review will support medicinal chemists and contribute in progression and development of synthesis of more potent chemotherapeutic drug candidates to mitigate the burden of this dreadful disease.

Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules

Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review

Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents

Recent Advances in the Development of Pyrazolopyridines As Anticancer Agents

Pyrimidine-fused Dinitrogenous Penta-heterocycles As a Privileged Scaffold for Anti-Cancer Drug Discovery

Application and SARs of Pyrazolo[1,5-a]pyrimidine As Antitumor Agents Scaffold.

Structural Activity Relationship-based Medicinal perceptions of Pyrazoline derivatives as Anti-Cancer Agents: A Review

Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds

Pyrazole Paradigms: Unveiling Synthetic Pathways and Unraveling Anti-Cancer Potential

Pharmacological activity and mechanism of pyrazines

Medicinal attributes of pyridine scaffold as anticancer targeting agents

Current Scenario of Pyridine/Quinoline-Sulfonamide Hybrids with Anticancer Potential (A Review)

Anticancer potential and structure activity studies of purine and pyrimidine derivatives: an updated review

Pyrazole Derivatives As Antitumor, Anti-Inflammatory and Antibacterial Agents

Advances in the Research of Pyrazole Derivatives with Antitumor Activity

Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect

Privileged Scaffolds or Promiscuous Binders: A Glance of Pyrrolo[2,1-F][1,2,4]Triazines and Related Bridgehead Nitrogen Heterocycles in Medicinal Chemistry

Current scenario of pyrazole hybrids with anti-breast cancer therapeutic applications

Novel pyrazolo[3,4-d]pyrimidine derivatives as potential antitumor agents: exploratory synthesis, preliminary structure-activity relationships, and in vitro biological evaluation.

Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential Antitumor Agents: Exploratory Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation

Design, facile synthesis and biological evaluations of novel pyrano[3,2-a]phenazine hybrid molecules as antitumor agents.